Clinical Research in Southampton
Southampton Children's Hospital

A A A Text only | Accessibility | Privacy and cookies

Home
About the Trust
Our services
Patients and visitors
Our hospitals
Education
Research
Working here
Contact us

Browse site A to Z

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Search results

Go To Simple Search

Search Type: Criteria:

You could also try: people (1000), residents (55)

BRC Research Theme Lead Designate JD and PS

Description: NIHR Southampton Biomedical Research Centre Research Theme Lead Designate National Institute for Health and Care Research (NIHR) Biomedical Research Centre (BR
Url: /Media/Southampton-Clinical-Research/Downloads/BRC-Research-Theme-Lead-Designate-JD-and-PS.docx

BRC_SDE Joint Funding Call CLEAN

Description: NIHR Southampton BRC and Wessex SDE joint funding call 2025 NIHR Southampton Biomedical Research Centre (BRC) and Wessex Secure Data Environment
Url: /Media/Southampton-Clinical-Research/Downloads/BRC-SDE-Joint-Funding-Call-CLEAN.pdf

WHP Funding Call 2

Description: Funding Call 2 About Wessex Health Partners: • Wessex Health Partners (WHP) is the region’s academic health science strategic partnership of NHS
Url: /Media/Southampton-Clinical-Research/Downloads/WHP-Funding-Call-2.pdf

Cystic fibrosis (CF) - patient information

Description: This booklet is for people who have a family history of cystic fibrosis (CF) and would like to understand more about
Url: /Media/UHS-website-2019/Patientinformation/Genetics/Cystic-fibrosis-CF-1428-PIL.pdf

Dacomitinib

Description: Chemotherapy Protocol LUNG CANCER – NON-SMALL CELL (NSCLC) DACOMITINIB Regimen • NSCLC - Dacomitinib Indication Dacomitinib for untreated EGFR-p
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lung-cancer-non-small-cellNSCLC/Dacomitinib.pdf

Papers Trust Board - 30 January 2020

Description: Date Time Location Chair Apologies Agenda Trust Board – Open Session 30/01/2020 9:00 - 11:45 Conference Room, Heartbeat Education
Url: /Media/UHS-website-2019/Docs/About-the-Trust/Trust-governance-and-corporate-docs/2020/Papers-Trust-Board-30-January-2020.pdf

Gilteritinib

Description: Chemotherapy Protocol Acute Myeloid Leukaemia GILTERITINIB Regimen  AML - Gilteritinib Indication Gilteritinib for treating relapsed/re
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/AML/Gilteritinib.pdf

CCP-UK Patient Data Notification v0.2 05MAY2022

Description: _______________________________________________ CCP-UK Patient Data Notification ________________________________________
Url: /Media/Southampton-Clinical-Research/Downloads/CCP-UK-Patient-Data-Notification-v0.2-05MAY2022.pdf

Risk-reducing bilateral salpingo-oophorectomy (RRBSO) - patient information

Description: This factsheet explains what a risk-reducing bilateral salpingo-oophorectomy (RRBSO) is, what the procedure involves, and what the potential advantages
Url: /Media/UHS-website-2019/Patientinformation/Womenshealth/Risk-reducing-bilateral-salpingo-oophorectomy-RRBSO-3080-PIL.pdf

SHC_application_2021_final2

Description: Southampton Hospitals Charity Research Funding Award 2022 Southampton Hospitals Charity (SHC) has actively engaged in raising funds for res
Url: /Media/Southampton-Clinical-Research/Grants/Download/SHC-application-2021-final2.docx

121 to 130 of 185

Previous … 11 12 13 14 15 … Next